1. Active acute leukaemia: should transplant be offered to all patients?. Issue 4 (24th June 2016) Authors: Avni, Batia; Shapira, Michael Y.; Resnick, Igor B.; Stepensky, Polina; Or, Reuven; Grisariu, Sigal Journal: Hematological oncology Issue: Volume 35:Issue 4(2017:Dec.) Page Start: 797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia – improved outcomes with similar toxicity. Issue 3 (23rd February 2019) Authors: Sheth, Vipul; Nachmias, Boaz; Grisariu, Sigal; Avni, Batia; Or, Reuven; Shapira, Michael Journal: Leukemia & lymphoma Issue: Volume 60:Issue 3(2019) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autologous transplant in multiple myeloma with an augmented conditioning protocol. Issue 11 (November 2013) Authors: Abu Zaid, Badran; Abdul-Hai, Ali; Grotto, Itamar; Dray, Lillian; Resnick, Igor B.; Tsirigotis, Panagiotis D.; Samuel, Simcha; Or, Reuven; Shapira, Michael Y. Journal: Leukemia & lymphoma Issue: Volume 54:Issue 11(2013:Nov.) Page Start: 2480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ex Vivo Induced Regulatory Human/Murine Mesenchymal Stem Cells as Immune Modulators. (13th May 2015) Authors: Hinden, Liad; Shainer, Reut; Almogi‐Hazan, Osnat; Or, Reuven Journal: Stem cells Issue: Volume 33:Number 7(2015:Jul.) Page Start: 2256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ex Vivo Induced Regulatory Human/Murine Mesenchymal Stem Cells as Immune Modulators. (13th May 2015) Authors: Hinden, Liad; Shainer, Reut; Almogi-Hazan, Osnat; Or, Reuven Journal: Stem cells Issue: Volume 33:Number 7(2015:Jul.) Page Start: 2256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fludarabine‐based reduced toxicity yet myeloablative conditioning is effective and safe particularly in patients with high‐risk thalassemia undergoing allogeneic transplantation. Issue 11 (1st August 2018) Authors: Sheth, Vipul; Grisariu, Sigal; Avni, Batia; Stepensky, Polina; Ashkenazi, Maayan; Shapira, Michael Y.; Or, Reuven Journal: Pediatric blood & cancer Issue: Volume 65:Issue 11(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Graves' orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?. Issue 5 (12th March 2018) Authors: Cima, Luminita Nicoleta; Lambrescu, Ioana Maria; Stejereanu, Lavinia; Colita, Anca; Or, Reuven; Fica, Simona Journal: Clinical case reports Issue: Volume 6:Issue 5(2018) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hematopoietic Stem Cell Transplantations for Primary Immune Deficiencies. Issue 5 (July 2015) Authors: Rousso, Sharon Z.; Shamriz, Oded; Zilkha, Amir; Braun, Jacques; Averbuch, Diana; Or, Reuven; Weintraub, Michael; Revel-Vilk, Shoshana; Stepensky, Polina Journal: Journal of pediatric hematology/oncology Issue: Volume 37:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hematopoietic Stem Cell Transplantations for Primary Immune Deficiencies: 3 Decades of Experience From a Tertiary Medical Center. Issue 5 (July 2015) Authors: Rousso, Sharon Z.; Shamriz, Oded; Zilkha, Amir; Braun, Jacques; Averbuch, Diana; Or, Reuven; Weintraub, Michael; Revel-Vilk, Shoshana; Stepensky, Polina Journal: Journal of pediatric hematology/oncology Issue: Volume 37:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Issue 9 (September 2015) Authors: Kharfan-Dabaja, Mohamed A.; Labopin, Myriam; Bazarbachi, Ali; Socie, Gerard; Kroeger, Nicolaus; Blaise, Didier; Veelken, Hendrik; Bermudez, Arancha; Or, Reuven; Lioure, Bruno; Beelen, Dietrich; Fegueux, Nathalie; Hamladji, Rose Marie; Nagler, Arnon; Mohty, Mohamad Journal: Leukemia research Issue: Volume 39:Issue 9(2015:Sep.) Page Start: 933 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗